p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias

Blood

Volumn 87, Issue 12, 1996, Pages 5213-5217

  Van Rhee, Frits ^a   Hochhaus, Andreas ^b   Lin, Feng ^b   Melo, Junia V ^b   Goldman, John M ^b   Cross, Nicholas C P ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; RECOMBINANT ALPHA INTERFERON;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029895899     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5213.bloodjournal87125213     Document Type: Article

References (30)

1. Westbrook CA, Hooberman AL, Spino C, Dodge DK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD: Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B study (8762). Blood 80:2983, 1992
2. Rowley JD: A new consistent chromosomal abnormality in chronic myeloid leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
3. Heisterkamp N, Stephenson JR, Groffen J, Hanssen PF, de Klein A, Bartram CR, Grosveld G: Localization of the c-abl oncogene to a translocation breakpoint in chronic myeloid leukaemia. Nature 306:239, 1983
4. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosome breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
5. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Fused transcript of abl and bcr genes in chronic myeloid leukaemia. Nature 315:550, 1985
6. BCR-ABL in chronic myeloid leukemia. Blood 70:233, 1987
7. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D: The chronic myeloid leukemia-specific p210 protein is the product of the bcr/abl hybrid gene. Science 233:21, 1986
8. Konopka JB, Watanabe SM, Witte ON: An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035, 1984
9. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G: Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33, 1987
10. Fainstein E, Marcelle C, Rosner A, Canaani E, Gale RP, Dreazen O, Smith SD, Croce CM: A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330:386, 1987
11. Chan LC, Karhi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R, Lawler SD, Groffen J, Foulkes JG, Greaves MF, Wiedemann LM: A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 325:635, 1987
12. Kurzrock R, Shtalrid M, Romero P, Kloetzer WS, Talpaz M, Trujillo JM, Blick M, Beran M, Gutterman JU: A novel c-abl protein in Philadelphia positive acute lymphoblastic leukaemia. Nature 325:631, 1987
13. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte O: Unique forms of the abl tyrosine kinase distinguish Ph′-positive CML from Ph′-positive ALL. Science 235:85, 1987
14. Kurzrock R, Shtalrid M, Talpaz M, Kloetzer WS, Gutterman JU: Expression of c-abl in Philadelphia-positive acute myeloid leukemia. Blood 70:1584, 1987
15. Heisterkamp N, Knoppel E, Groffen J: The first bcr gene intron contains breakpoints in Philadelphia positive leukemias. Nucleic Acids Res 116:1069, 1988
16. Secker-Walker LM, Craig JM: Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: A review. Leukemia 7:147, 1993
17. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M: Prolonged survival in chronic myeloid leukemia after cytogenetic response to interferon-α therapy. Ann Intern Med 122:254, 1995
18. Cross NCP, Hughes TP, Lin F, O'Shea P, Bungey J, Marks DI, Ferrant A, Martiat P, Goldman JM: Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: Correlations with acute graft-versus-host disease and relapse. Br J Haematol 84:67, 1993
19. Cross NCP, Lin F, Chase A, Bungey J, Hughes TP, Goldman JM : Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia after bone marrow transplantation. Blood 82:1929, 1993
20. van Rhee F, Marks DI, Lin F, Szydlo RM, Treleaven J, Hochhaus A, Delord C, Cross NCP, Goldman JM: Quantification of residual disease in Philadelphia positive acute lymphoblastic leukemia: Comparison of blood and bone marrow. Leukemia 9:329, 1995
21. Hochhaus A, Reiter A, Melo JV, Skladny H, Shepherd PCA, Sick C, Clark RE, Tobler A, Bell A, Hehlmann R, Goldman JM, Cross NCP: Atypical BCR-ABL transcripts in chronic myelogenous leukemia patients detected by multiplex polymerase chain reaction. Blood 86:526a, 1995 (abstr, suppl 1)
22. Melo JV, Myint H, Galton DAG, Goldman JM: p190 BCR-ABL chronic myeloid leukemia: The missing link with chronic myelomonocytic leukemia? Leukemia 8:208, 1994
23. Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R: Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia positive acute lymphoblastic leukemia. Blood 78:2411, 1991
24. Maurer J, Janssen WG, Thiel E, van Denderen J, Ludwig W-F, Aydemir Ü, Heinze B, Fonatsch F, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR: Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 337:1055, 1991
25. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P: Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118, 1995
26. Kunieda Y, Okabe M, Kurosawa M, Itaya T, Kakinuma M, Miyazaki T: Chronic myeloid leukemia presenting ALL-type BCR/ ABL transcript. Ann Hematol 69:189, 1994
27. BCR-ABL in chronic myeloid leukemia may correlate with disease progression. Leukemia 5:191, 1991
28. Seelig R, Schranz P, Bottner C, Neubauer A, Seelig HP, Renz M: The chronic myelocytic cell line K562 contains minor (m) as well as major (M) bcr/abl fusion mRNAs. Leukemia 7:1886, 1993
29. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277, 1986
30. Guo JQ, Lian JY, Xian YM, Lee MS, Deisseroth AB, Stass SA, Champlin RE, Talpaz M, Wang YJ, Arlinghaus RB: BCR-ABL protein expression in peripheral blood cells of chronic myeloid leukemia patients undergoing therapy. Blood 83:3629, 1994